Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization.

Xu X, Gao D, Yuan X, Liu LI, Zhang X, Liang X, Chen S, Ai M, Chen BO, Shi D, Yang Z, Hoffman RM, Xu J.

Anticancer Res. 2019 Mar;39(3):1129-1134. doi: 10.21873/anticanres.13221.

PMID:
30842141
2.
3.

Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization.

Zhang JB, Chen Y, Zhang B, Xie X, Zhang L, Ge N, Ren Z, Ye SL.

Eur J Gastroenterol Hepatol. 2011 Sep;23(9):787-93. doi: 10.1097/MEG.0b013e32834902dd.

PMID:
21730869
5.

Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.

Liu C, Sun L, Xu J, Zhao Y.

World J Surg Oncol. 2016 Apr 2;14:100. doi: 10.1186/s12957-016-0855-z.

7.

Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.

Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX.

World J Gastroenterol. 2017 Nov 7;23(41):7415-7424. doi: 10.3748/wjg.v23.i41.7415.

8.

Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.

Lee JW, Oh JK, Chung YA, Na SJ, Hyun SH, Hong IK, Eo JS, Song BI, Kim TS, Kim DY, Kim SU, Moon DH, Lee JD, Yun M.

J Nucl Med. 2016 Apr;57(4):509-16. doi: 10.2967/jnumed.115.167338. Epub 2016 Jan 7.

9.

Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.

Wang Y, Chen Y, Ge N, Zhang L, Xie X, Zhang J, Chen R, Wang Y, Zhang B, Xia J, Gan Y, Ren Z, Ye S.

Ann Surg Oncol. 2012 Oct;19(11):3540-6. doi: 10.1245/s10434-012-2368-5. Epub 2012 Apr 25.

PMID:
22532305
10.

Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma.

Jun CH, Ki HS, Lee HK, Park KJ, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS.

World J Gastroenterol. 2013 Jan 14;19(2):284-9. doi: 10.3748/wjg.v19.i2.284.

11.

Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.

Hao MZ, Lin HL, Chen QZ, Hu YB, Chen JB, Zheng JX, Zhou D, Zhang H.

J Dig Dis. 2017 Jan;18(1):31-39. doi: 10.1111/1751-2980.12435.

PMID:
27987344
12.
13.
15.

Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.

Hiraoka A, Ishimaru Y, Kawasaki H, Aibiki T, Okudaira T, Toshimori A, Kawamura T, Yamago H, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K.

Oncology. 2015;89(3):167-74. doi: 10.1159/000381808. Epub 2015 May 12.

PMID:
25999038
16.

Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients.

Shim JH, Park JW, Kim JH, An M, Kong SY, Nam BH, Choi JI, Kim HB, Lee WJ, Kim CM.

Cancer Sci. 2008 Oct;99(10):2037-44. doi: 10.1111/j.1349-7006.2008.00909.x.

17.

Transcatheter arterial chemoembolization for infiltrative hepatocellular carcinoma: clinical safety and efficacy and factors influencing patient survival.

Han K, Kim JH, Yoon HM, Kim EJ, Gwon DI, Ko GY, Yoon HK, Ko HK.

Korean J Radiol. 2014 Jul-Aug;15(4):464-71. doi: 10.3348/kjr.2014.15.4.464. Epub 2014 Jul 9.

18.
19.
20.

Expression of Phosphorylated AMP-Activated Protein Kinase Predicts Response to Transarterial Chemoembolization in Postoperative Cases of Hepatocellular Carcinoma.

Zheng LY, Wu L, Lu J, Zou DJ, Huang Q.

Medicine (Baltimore). 2016 Mar;95(11):e2908. doi: 10.1097/MD.0000000000002908.

Supplemental Content

Support Center